Accueil>>Mitragynine-d3

Mitragynine-d3 (Synonyms: 9methoxy Corynantheidine-d3)

Catalog No.GC47686

A neuropeptide with diverse biological activities

Products are for research use only. Not for human use. We do not sell to patients.

Mitragynine-d3 Chemical Structure

Cas No.: N/A

Taille Prix Stock Qté
500 μg
163,00 $US
En stock
1 mg
294,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Mitragynine-d3 is an analytical reference material intended for use as an internal standard for the quantification of mitragynine by GC- or LC-MS. Mitragynine is categorized as an opioid.1,2 Mitragynine and its derivatives have been identified in products sold as incense.3 This product is intended for research and forensic applications.

1.Matsumoto, K., Mizowaki, M., Suchitra, T., et al.Central antinociceptive effects of mitragynine in mice: Contribution of descending noradrenergic and serotonergic systemsEur. J. Pharmacol.317(1)75-81(1996) 2.Takayama, H., Ishikawa, H., Kurihara, M., et al.Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: Discovery of opioid agonists structurally different from other opioid ligandsJ. Med. Chem.45(9)1949-1956(2002) 3.Kikura-Hanajiri, R., Uchiyama, N., and Goda, Y.Survey of current trends in the abuse of psychotropic substances and plants in JapanLeg. Med. (Tokyo)13(3)109-115(2011)

Avis

Review for Mitragynine-d3

Average Rating: 5 ★★★★★ (Based on Reviews and 17 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Mitragynine-d3

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.